Valuation: Biosenta Inc.

Market Cap 1.84M 1.31M 1.15M 1.06M 976K 127M 1.88M 12.66M 4.98M 61.96M 4.93M 4.83M 213M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 8.45M 6.03M 5.27M 4.86M 4.48M 581M 8.64M 58.12M 22.86M 284M 22.65M 22.15M 979M EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
87.79%
Yield 2024 *
-
Yield 2025 -
1 week+400.00%
3 months-28.57%
6 months-50.00%
Current year-50.00%
1 week 0.04
Extreme 0.045
0.05
1 month 0.01
Extreme 0.01
0.05
Current year 0.01
Extreme 0.01
0.12
1 year 0.01
Extreme 0.01
0.17
3 years 0.01
Extreme 0.01
0.89
5 years 0.01
Extreme 0.01
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 2019-07-15
Director TitleAgeSince
Chairman 90 2019-07-15
Director/Board Member - 2011-10-04
Chairman 65 2015-02-16
Date Insider Type Main position Quantity % Market Cap.
5/2/26 Option

Chief Executive Officer

-210,000 0.6040%
5/2/26 Option

Director

-807,000 2.3210%
3/3/26 Option

Chairman

60,000 0.1741%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+400.00%-64.29%-85.92% 1.31M
-0.12%+1.36%-2.58%-15.47% 43.45B
-1.06%+1.77%+1.52%-0.11% 23.24B
-2.42%-0.25%-24.97%-37.46% 11.65B
-0.98%-0.11%+20.75%-3.17% 5.53B
+0.89%-1.73%+12.58%-60.19% 3.6B
-3.35%-6.84%+13.28%+9.85% 3.31B
+1.72%+2.36%+17.84%+28.12% 2.92B
+1.64%+4.11%+3.46%+63.35% 1.28B
-0.92%+7.91%+113.00%+748.83% 873M
Average -0.46%+0.68%+9.06%+64.78% 9.59B
Weighted average by Cap. -0.68%+1.40%-0.09%-5.17%

Financials

2024 2025
Net sales 1.38K 984.3 860.18 793.75 731.64 94.79K 1.41K 9.49K 3.73K 46.42K 3.7K 3.62K 160K 1.21K 864.38 755.38 697.05 642.5 83.24K 1.24K 8.33K 3.28K 40.77K 3.25K 3.17K 140K
Net income -2.23M -1.59M -1.39M -1.28M -1.18M -153M -2.28M -15.33M -6.03M -74.99M -5.97M -5.84M -258M -2.51M -1.79M -1.56M -1.44M -1.33M -172M -2.56M -17.24M -6.78M -84.36M -6.72M -6.57M -290M
Net Debt 5.54M 3.96M 3.46M 3.19M 2.94M 381M 5.67M 38.14M 15M 187M 14.86M 14.53M 642M 6.61M 4.72M 4.12M 3.8M 3.51M 454M 6.75M 45.46M 17.88M 222M 17.71M 17.32M 766M
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume
26-07-16 $0.0500 +11.11% 152,500
26-07-15 $0.0450 +350.00% 7,000